Pyxis Oncology, Inc. (PYXS) has a market capitalization of $106.81M and trades at $1.70. The 52-week range is 0.833-5.55.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.3, Earnings Per Share (EPS) of $-1.28, annual revenue of $13.86M.
The stock has a beta of 1.42, operates in the Healthcare sector.
